In March, notable health tech companies announced substantial funding rounds aimed at enhancing their services and technologies. Navina raised $55 million to advance its AI copilot technologies for value-based care, while Proscia secured $50 million for its pathology software to expedite drug discovery and diagnostics. Vori Health garnered $53 million to support its comprehensive musculoskeletal care across virtual and in-person platforms. These financial boosts signal the increasing investment in health technology as companies look to improve patient outcomes and streamline medical care.
Navina's $55 million Series C funding was led by Goldman Sachs and will be used to enhance their AI technology, aiming for better value-based care models.
Proscia raised $50 million to advance its Concentriq platform, which accelerates drug discovery and diagnostics.
Vori Health's $53 million Series B funding will support their comprehensive musculoskeletal care services, combining virtual and in-person treatments.
These funding rounds underline the growing investment in innovative health tech solutions, emphasizing value-based care and enhanced patient services.
Collection
[
|
...
]